Viewing Study NCT02279758

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:16 AM
Ignite Modification Date: 2026-02-26 @ 12:43 AM
Study NCT ID: NCT02279758
Status: UNKNOWN
Last Update Posted: 2014-10-31
First Post: 2014-07-07
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Pilot Study of Metformin Treatment in Patients With Well-differentiated Neuroendocrine Tumors
Sponsor: Instituto do Cancer do Estado de São Paulo
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Well-differentiated Neuroendocrine Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neuroendocrine Tumors View
None The Mammalian Target of Rapamycin (mTOR) View
None metformin View